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The role of tissue factor in patients undergoing
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Donald J. Adam, MD,a Birmingham, UK
Background: Ruptured abdominal aortic aneurysm (AAA) is associated with the development of a procoagulant and
hypofibrinolytic state. Tissue factor (TF) and its naturally occurring inhibitor, tissue factor pathway inhibitor (TFPI),
play a central role in the initiation and progression of such a hypercoagulable state, but their role in patients undergoing
open AAA repair has not previously been examined.
Methods: A prospective study was conducted of 17 patients undergoing elective AAA repair and 10 patients undergoing
emergency AAA repair. Blood was taken before induction, and 5minutes, 24 hours, and 48 hours after aortic cross-clamp
release and assayed for plasma TF, TFPI, tissue plasminogen activator (t-PA), plasminogen activator inhibitor (PAI), and
thrombin-activatable fibrinolysis inhibitor (TAFI) activities.
Results: TF activity was significantly higher at all time points in patients with ruptured AAA compared with nonruptured
AAA. The median (interquartile range, IRQ) TF activity (AU/mL) was 9.9 vs 3.2 (IRQ, 5.9 to 12.6 vs 2.0 to 7.6; P 
.005) at preinduction; 10.7 vs 1.5 (IRQ, 9.2 to 18.3 vs 0.1 to 6.6; P  .003) at 5 minutes after clamp release; 9.5 vs 3.3
(IRQ, 7.0 to 13.5 vs 1.0 to 7.9; P  .013) at 24 hours, and 9.6 vs 3.9 (IRQ, 7.6 to 12.6 vs 2.4 to 8.7; P  .006) at 48
hours. TFPI levels were not significantly different between ruptured AAA and nonruptured AAA before or during
operation but became significantly elevated at 24 and 48 hours in patients who had undergone repair of ruptured AAA.
Ruptured AAA repair was associated with a hypofibrinolytic state compared with nonruptured AAA.
Conclusions: The present study has demonstrated for the first time, to our knowledge, that ruptured AAA is associated
with significantly higher perioperative levels of circulating TF compared with nonruptured AAA. Furthermore, in the
immediate perioperative period, the high levels of TF are not associated with a corresponding rise in TFPI levels,
indicating an unopposed prothrombotic state. Direct inhibition of TF by administration of anti-TF antibodies or
recombinant TFPI remains to be evaluated in subjects presenting with hemorrhage due to ruptured AAA, but if given
early enough, it may attenuate the early deleterious effects of unopposed TF expression and ultimately contribute to
improved outcomes. (J Vasc Surg 2007;46:682-6.)Ruptured abdominal aortic aneurysm (AAA) is associ-
ated with the development of a procoagulant and hypofi-
brinolytic state.1,2 The most obvious manifestation of this
hemostatic derangement is disseminated intravascular co-
agulation (DIC), which leads to thrombotic and hemor-
rhagic complications. Disorders of coagulation and fibrino-
lysis have also been implicated in the pathogenesis of
myocardial infarction (MI), multiple organ dysfunction
syndrome (MODS), acute respiratory distress syndrome
(ARDS), and the systemic inflammatory response syn-
drome (SIRS), all of which may occur in patients undergo-
ing open AAA repair.3-5
Tissue factor (TF) and its naturally occurring inhibitor,
tissue factor pathway inhibitor (TFPI), play a central role in
the development of these conditions predominantly
through their role in the crosstalk between coagulation and
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682inflammation.5 TF is the most important initiator of intra-
vascular coagulation. After vascular injury, TF is rapidly
expressed and triggers coagulation through the activation
of factors VII and X. Ultimately TF is inhibited by TFPI,6
which acts by reversibly inhibiting factor Xa and the factor
VIIa/TF complex, thereby limiting thrombin production.
An understanding of the role of TF and TFPI, and their
relationship with other markers of coagulation in patients
undergoing open AAA repair may point to potential ther-
apeutic targets aimed at reducing morbidity and mortality.
The present study compared serial levels of markers of
coagulation (TF, TFPI) and fibrinolysis, including tissue
plasminogen activator (t-PA), plasminogen activator inhib-
itor (PAI), and thrombin-activatable fibrinolysis inhibitor
(TAFI), in patients undergoing open repair of ruptured and
nonruptured AAA.
METHODS
Patients. After local ethical approval, a prospective
study was conducted of 17 patients (15 men and 2 women)
with a median age of 72.5 years (range, 60 to 81 years)
undergoing elective repair of asymptomatic infrarenal AAA,
and 10 patients (9 men and 1 woman) with a median age of
75 years (range, 65 to 86 years) undergoing emergency
repair of ruptured AAA. In patients undergoing elective
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(range, 53 to 90 mm). All subjects operated on for rup-
tured AAA had at least one documented episode of hypo-
tension (systolic blood pressure 100 mm Hg) preopera-
tively, and ruptured AAAwas confirmed at operation by the
presence of fresh intraperitoneal or retroperitoneal blood.
The median delay to surgery from onset of symptoms in
patients with ruptured AAA was 4.5 hours.
All subjects underwent repair through a transverse su-
praumbilical incision with infrarenal clamping. No patient
with a ruptured AAA was given systemic heparin; however,
those undergoing elective AAA repair received 5000 units
of heparin immediately before aortic cross-clamping.
Sample collection and assay methods. After discard-
ing the first 10 mL, arterial blood was sampled from an
indwelling radial arterial line immediately before induction
of anesthesia (sample A) and 5 minutes (sample B), 24
hours (sample C), and 48 hours (sample D) after aortic
clamp release. Samples were placed immediately on ice and
centrifuged within 30minutes of collection at 1400g for 30
minutes at 4°C, and the resultant plasma and serum were
stored at 80°C for later batch analysis. Commercially
available chromogenic assays were used to determine the
activity of t-PA (Coatest t-PA, Chromogenix, Möndal,
Sweden), PAI (Coaset PAI, Chromogenix), TF (Ac-
tichrome TF, American Diagnostica, Greenwich, CT),
TFPI (Actichrome TFPI, American Diagnostica), and
TAFI (Actichrome TAFI, AmericanDiagnostica). The nor-
mal range for each hemostatic marker was determined by
the manufacturer of the assay.
Statistical analysis. Data were analyzed using SPSS
11.0.1 (SPSS Inc, Chicago, Ill). Nonruptured AAA and rup-
tured AAA were compared using the Mann-Whitney U test.
In subjects who died, data up to the point where they died
were used in the data set and analysis. Because the data were
not normally distributed, changes in parameters over time
were analyzed using the Wilcoxon signed ranks test, and the
Spearman rank test was used to correlate the hematologic and
clinical variables. A value ofP .05was taken tobe statistically
significant. More complicated analysis was not performed
because we determined that, with the number of subjects in
the study, this would not yield much additional information
Table I. Clinical and operative data in subjects operated o
aneurysm




AAA size (mm) 60 (53-
Onset of symptoms to surgery (hr) —
Intraoperative
Total operation time (min) 195 (85-
Clamp time (min) 68 (40-
Measured blood loss (mL) 2450 (100
AAA, Abdominal aortic aneurysm.
*Mann-Whitney U test.and would only serve to cloud the issue.RESULTS
Clinical data. All subjects undergoing elective repair
of asymptomatic infrarenal AAA survived to discharge from
hospital. Of those undergoing repair of ruptured AAA, the
mortality rate was 50% (5/10). One patient died intraop-
eratively of uncontrollable hemorrhage, one patient who
developed DIC and was anuric during surgery died of
circulatory failure in the theatre recovery room, and three
died of MODS and ARDS in the late postoperative period.
Clinical and intraoperative details are shown in Table I.
Markers of fibrinolysis. Because we have previously
assessed the effect of AAA rupture on the fibrinolytic sys-
tem, including D-dimer,1 we elected to only measure t-PA
and PAI activity in this present study to allow a reference
point to aid in the interpretation of the more novel coagu-
lation factors studied. A comparison of hematologic vari-
ables at various time points between ruptured and nonrup-
tured abdominal aortic aneurysms is presented in Table II.
Before induction of anesthesia, t-PA activity (IU/mL)
was significantly lower in patients with ruptured AAA, with
a median value of 0.12 vs non-ruptured AAA at 0.54
(interquartile range [IQR], 0.08 to 0.41 vs 0.18 to 1.58;
P .036). At all other time points, there was no significant
difference in t-PA activity between the two groups, and no
significant change in t-PA activity levels was observed with
time in either group.
PAI activity (AU/mL) was significantly higher before
and during operation in patients with ruptured AAA, with a
median preinduction value of 36.9 vs nonruptured AAA of
9.9 (IRQ, 25.3 to 38.4 vs 1.3 to 13.2; P  .002), and at 5
minutes after clamp release it was 37.5 vs 11.4 (IRQ, 11.9
to 38.8 vs 9.1 to 23.0; P .046). In ruptured AAA repair,
PAI activity remained elevated out to 24 hours but then fell
significantly at 48 hours compared with preinduction levels
(36.9 [IRQ, 25.3 to 38.4] to 13.5 [IRQ, 9.3to 21.0]; P
.017). In nonruptured AAA repair, PAI activity was signif-
icantly increased at 24 and 48 hours compared with prein-
duction levels (preinduction: 9.9 [IRQ, 1.3 to 13.2] vs 24
hours: 11.6 [IRQ, 9.7 to 26.4]; P .03; vs 48 hours: 16.3
[IRQ, 11.2 to 29.4]; P  .006).
Tissue factor. TF activity was significantly higher at all















0-60time points in patients with ruptured AAA vs nonruptured
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nonruptured AAA was 9.9 vs 3.2 (IRQ, 5.9 to 12.6 vs 2.0
to 7.6; P  .005); at 5 minutes after clamp release it was
10.7 vs 1.5 (IRQ, 9.2 to 18.3 vs 0.1 to 6.6; P .003); at 24
hours it was 9.5 vs 3.3 [IRQ, 7.0 to 13.5 vs 1.0 to 7.9; P
.013); and at 48 hours it was 9.6 vs 3.9 (IRQ, 7.6 to 12.6
vs 2.4 to 8.7; P  .006; Fig). There was no significant
change in TF activity observed with time in either group.
Amongst the group as a whole, preinduction TF activity
levels correlated significantly with preinduction levels of
t-PA (Spearman’s coefficient [SC],0.531; P .008) and
PAI activity (SC, 0.633; P  .001).
Tissue factor pathway inhibitor. TFPI levels were
not significantly different between ruptured AAA and non-
ruptured AAA before or during operation. At 24 and 48
hours postoperatively, however, TFPI levels were signifi-
cantly higher in subjects who had undergone repair of
ruptured AAA. The median (IQR) TFPI activity (U/mL)
vs nonruptured AAA at 24 hours was 2.2 vs 1.7 (IRQ, 1.9
to 2.6 vs 1.5 to 2.0; P  .013), and at 48 hours it was 2.5
vs 1.9 (IRQ, 2.3 to 2.6 vs 1.1 to 2.3; P .006). TFPI levels
in elective AAA repair correlated significantly with prein-
duction (SC, 0.630; P  .007) and 5-minute postclamp
(SC, 0.532; P  .028) TF activity levels, but no associa-
tion was observed in the ruptured AAA group.
Thrombin-activatable fibrinolysis inhibitor. No
significant difference in TAFI levels was found between
ruptured AAA and nonruptured AAA at any time point.
Overall however, there was a significant drop in TAFI levels
Table II. Comparison of hematologic variables at various
aortic aneurysms
Assay (normal range) Sample point*
N




















AAA, Abdominal aortic aneurysm; TPA, tissue plasminogen activator; PA
inhibitor; TAFI, thrombin-activatable fibrinolysis inhibitor.
*Sample A, Immediately before induction of anesthesia; sample B, 5minutes
sample D, 48 hours after aortic cross-clamp release.
†Mann-Whitney U test.at 5 minutes after aortic clamp release, which remainedsignificantly lower at 24 hours. The median (IQR) prein-
duction TAFI (g/mL) value was 52.5 vs 36.7 (IRQ, 39.9
to 64.3 vs 23.4 to 54.9; P  .001) at 5 minutes postclamp
vs 39.1 (IRQ, 28.5 to 52.5; P .008) at 24 hours. Among
points between ruptured and nonruptured abdominal
tured AAA, median
ange) (n  17)
Ruptured AAA, median
(range) (n  10) P†
4 (0.10-2.45) 0.12 (0.06-7.90) .036
5 (0.10-3.69) 0.38 (0.08-7.60) .312
0 (0.10-5.57) 0.35 (0.09-7.30) .829
8 (0.10-1.36) 0.99 (0.15-2.1) .297
.9 (0.1-21.7) 36.9 (2.6-38.8) .001
.4 (2.8-29.4) 37.5 (0.1-39.3) .048
.6 (2.2-32.1) 37.0 (0.1-39.4) .124
.3 (0.8-149.2) 13.5 (5.9-35.3) .570
.2 (0.1-30.0) 9.9 (3.7-20.3) .005
.5 (0.1-31.2) 10.7 (6.7-23.9) .003
.3 (0.4-17.2) 9.5 (3.1-18.7) .013
.9 (1.0-16.7) 9.6 (4.4-19.5) .006
.1 (0.1-2.8) 1.9 (1.3-2.4) .187
.0 (0.9-3.6) 1.9 (1.3-2.8) .264
.7 (0.5-3.0) 2.2 (1.6-2.9) .013
.9 (0.5-3.0) 2.5 (1.2-2.8) .006
.9 (16.6-81.5) 49.0 (39.0-77.3) .863
.7 (1.0-77.5) 43.2 (20.6-66.0) .309
.1 (18.2-100.0) 46.4 (17.7-63.7) .675
.9 (1.0-92.0) 46.3 (4.3-76.2) .537
minogen activator inhibitor; TF, tissue factor; TFPI, tissue factor pathway
ortic cross clamp release; sample C, 24 hours after aortic cross-clamp release;
Figure. Serial box plot compares the change in tissue factor (TF)
activity over time after ruptured and nonruptured abdominal aortic
aneurysm repair. The horizontal line in the middle of each box
indicates the median; the top and bottom borders of the box mark
























after athe nonruptured AAA group, the acute fall in TAFI after
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time point (SC, 0.500; P  .041).
DISCUSSION
The present study has demonstrated for the first time,
to our knowledge, that ruptured AAA is associated with
significantly higher perioperative levels of circulating TF
compared with nonruptured AAA. Furthermore, in the
immediate perioperative period, the high levels of TF are
not associated with a corresponding rise in TFPI levels,
indicating an unopposed prothrombotic state.
Currently, no published data have examined TF or
TFPI in patients with ruptured AAA or compared periop-
erative changes in these markers between ruptured and
nonruptured AAA. Yamazumi et al7 measured TF levels in
patients undergoing elective AAA repair and found no corre-
lation between TF and the other hemostatic markers or aneu-
rysm morphology. TFPI levels showed a significant correla-
tion with thrombin-antithrombin complex, D-dimer, fibrin
degradation products, -2 plasmin inhibitor, and aneurysm
size and tortuosity.7 Nomura et al8 measured TFPI levels in
patients with nonruptured AAA before elective repair and
found significantly higher levels compared with age-matched
controls.8
TF has been measured in trauma patients and in sub-
jects undergoing cardiopulmonary resuscitation after car-
diac arrest, populations sharing similar global ischemia and
reperfusion characteristics with those with ruptured
AAA.5,9 In both of these groups, TF levels were signifi-
cantly higher than in control subjects and gradually de-
creased during a 4-day period.9 The observed elevations in
TF were associated with a reduction in TFPI levels, indicat-
ing activation of the extrinsic coagulation pathway without
adequate TFPI generation.10
In the present study, the difference in TFPI levels
between the groups was not significant at induction or 5
minutes after aortic declamping, despite significantly
higher TF levels in patients with ruptured AAA. The ab-
sence of any correlation between early perioperative TF and
TFPI in patients with a ruptured AAA, where a significant
negative correlation existed for nonruptured AAA, suggests
that an imbalance exists between these two opposing fac-
tors in this group of patients. Unlike the previous work on
trauma patients, TFPI levels significantly rose at 24 and 48
hours in patients with ruptured AAA. This suggests an early
lag phase in the TFPI response, followed by a catch-up
phase in an attempt to inhibit the sustained TF response.
This present study confirmed our previous findings that
ruptured AAA is associated with a hypofibrinolytic state
compared with nonruptured AAA.1,11 The hypofibrino-
lytic state persisted to 24 hours in the ruptured AAA group
before returning to a similar level as the nonruptured AAA
group at 48 hours. TAFI couples the coagulation and
fibrinolytic cascades, such that the action of the former
down-regulates the activity of the latter.12 To our knowl-
edge, the present study is the first to assess TAFI levels in
patients with AAA.Despite demonstrating that ruptured AAA was associ-
ated with an inhibition of fibrinolysis, we found no signif-
icant difference in TAFI levels between the two groups.
Similar discrepancies between PAI and TAFI have been
observed in subjects with acute coronary syndrome,13 with
differences in weight or different responses to inflammation
or shock being implicated. Studies in human sepsis suggest
that both PAI and TAFI are responsible for mediating
inhibition of fibrinolysis, but PAI appears to be involved
early in the septic process, with TAFI responsible for ongo-
ing fibrinolytic inhibition in the later stages.14
No significant variations in TAFI levels have been ob-
served between subjects with DIC and controls.15 In the
present study,we observed a significant fall inTAFI levels after
aortic declamping, which only returned to baseline values at
48 hours. This acute change in TAFI did not correlate with
the other fibrinolytic markers, although the fall in TAFI did
correlate with the change in TF levels after aortic declamping,
suggesting an inherent link with thrombin production.
What is the clinical value of these findings? Changes in
coagulation and fibrinolysis play a major role in the mor-
bidity and mortality associated with critical illness. A hypo-
fibrinolytic state occurring during ruptured AAA repair has
been shown to be associated with the development of
perioperative myocardial injury.11 Elevated TF levels after
trauma have been associated with DIC, SIRS, ARDS, and
MODS.5 The likely mechanism behind these complications
is intravascular and intra-alveolar fibrin deposition; how-
ever, it is becoming increasingly clear that coagulation and
inflammation are inextricably linked, with inflammation
activating coagulation, and vice versa.16 TF is the principal
initiator of coagulation and an important modulator of
inflammation, such that an exaggerated or poorly con-
trolled response may contribute to the development of
MODS and the higher mortality observed in subjects with
a ruptured AAA.
In our study, TF activity preinduction was significantly
lower among survivors compared with nonsurvivors; how-
ever, this is confounded by the observation that half of sub-
jects with a ruptured AAA died, whereas none in the nonrup-
tured group died, and this finding is therefore more likely to
reflect the difference between the two different AAA groups
rather than an true association with mortality. The small
number of subjects hampered detailed subgroup analysis, and
thus it was not possible to assess whether there were any
differences in hematologic variables between survivors and
nonsurvivors or to assess the impact of other variables such as
clamp time, degree of shock, and blood loss.
CONCLUSION
This study has demonstrated that ruptured AAA is asso-
ciated with an increased TF response that is unopposed by
TFPI in the early perioperative period. Because a perioperative
hypofibrinolytic state has previously been shown to be associ-
ated with myocardial injury, it is possible that this early pro-
thrombotic state may also contribute to the poor outcome
seen with ruptured AAA. Direct inhibition of TF by adminis-
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October 2007686 Hobbs et altration of anti-TF antibodies or recombinant TFPI has been
shown to reduce DIC in sepsis.6 The effect of this form of
intervention in patients presenting with hemorrhage due to
ruptured AAAormajor trauma remains to be evaluated, but if
given early enough, it may attenuate the early deleterious
effects of unopposed TF expression and ultimately contribute
to improved outcomes.
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